Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics

Supportive Care in Cancer

Volumn 21, Issue 11, 2013, Pages 3103-3107

  Kim, Josephine S ^a   Ward, Kristy K ^a   Shah, Nina R ^a   Saenz, Cheryl C ^a   McHale, Michael T ^a   Plaxe, Steven C ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antibiotics; Clostridium difficile; Hysterectomy; Infection; Ovarian cancer

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; HYSTERECTOMY; INFECTION RISK; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT DURATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COMORBIDITY; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; HYSTERECTOMY; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84885629462     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-013-1888-2     Document Type: Article

References (18)

1. Lipp MJ, Nero DC, Callahan MA (2012) Impact of hospital-acquired Clostridium difficile. J Gastroenterol Hepatol 27(11):1733-1737. doi: 10.1111/j.1440-1746.2012.07242.x
2. Kyne L, Sougioultzis S, McFarland LV, Kelly CP (2002) Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23(11):653-659. doi: 10.1086/501989
3. Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330(4):257-262. doi: 10.1056/nejm199401273300406
4. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN (2007) Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 142(7):624-631. doi: 10.1001/archsurg.142.7.624
5. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT (2007) The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 8(6):557-566. doi: 10.1089/sur.2006.062
6. Lo Vecchio A, Zacur GM (2012) Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol 28(1):1-9. doi: 10.1097/MOG.0b013e32834bc9a9
7. McCollum DL, Rodriguez JM (2012) Detection, treatment, and prevention of Clostridium difficile infection. Clin Gastroenterol Hepatol 10(6):581-592. doi: 10.1016/j.cgh.2012.03.008
8. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67(3):742-748. doi: 10.1093/jac/dkr508
9. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S19-31. doi: 10.1086/521859
10. Wistrom J, Norrby SR, Myhre EB, Eriksson S, Granstrom G, Lagergren L, Englund G, Nord CE, Svenungsson B (2001) Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47(1):43-50. doi: 10.1093/jac/47.1.43
11. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543-1549. doi: 10.1086/523582
12. Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K (1996) Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol 61(3):369-372
13. Masciullo V, Mainenti S, Lorusso D, Margariti PA, Scambia G (2010) Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: case report and review of the literature. Obstet Gynecol Int 2010. doi: 10.1155/2010/74978
14. Southern WN, Rahmani R, Aroniadis O, Khorshidi I, Thanjan A, Ibrahim C, Brandt LJ (2010) Postoperative Clostridium difficile-associated diarrhea. Surgery 148(1):24-30. doi: 10.1016/j.surg.2009.11.021
15. Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L (2008) Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 46(12):1838-1843. doi: 10.1086/588291
16. Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP (2007) Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 59(5):990-995. doi: 10.1093/jac/dkm014
17. Talpaert MJ, Gopal Rao G, Cooper BS, Wade P (2011) Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 66(9):2168-2174. doi: 10.1093/jac/dkr253
18. Aldeyab MA, Kearney MP, Scott MG, Aldiab MA, Alahmadi YM, Darwish Elhajji FW, Magee FA, McElnay JC (2012) An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 67(12):2988-2996. doi: 10.1093/jac/dks330